Register entry
- Registered sites
- 2
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Poland
Authorisation
Registered operations
Analytical testing2Active ingredient (API) manufacture2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Polpharma Biologics S.A. | Ul. Spoldzielcza 4, Duchnice, Ozarow Mazowiecki 05-850, Poland (POL) | Analytical testing, Active ingredient (API) manufacture | 3027094019849736088 |
| Polpharma Biologics S.A. | ul. Trzy Lipy 3, Gdansk, 80-172, Poland (POL) | Analytical testing, Active ingredient (API) manufacture | 3013195136850663938 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ranibizumab | solution, concentrate | 82775-100BULK INGREDIENT |
Compare
Comparable companies in Poland
- STERISCIENCE SP Z O O1 site · 16 NDC
- ZAKLADY FARMACEUTYCZNE POLPHARMA S A1 site · 6 NDC
- NOBILUS ENT TOMASZ KOZLUK1 site · 3 NDC
- NARODOWE CENTRUM BADAN JADROWYCH1 site · 1 NDC
Enquiry
Common questions
- Is Polpharma Biologics S.A. FDA approved?
- Polpharma Biologics S.A. holds 2 FDA-registered establishments in Poland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Polpharma Biologics S.A.'s drugs manufactured?
- The FDA register lists Duchnice; Gdansk. Registered operations: analytical testing, active ingredient (API) manufacture.
- What drugs does Polpharma Biologics S.A. make?
- 1 product is listed under Polpharma Biologics S.A. in the openFDA NDC Directory, most often as solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.